CSPC PHARMA (01093): SYS 6040 (antibody-drug conjugate) has received approval for clinical trials.

CSPC PHARMA (01093) announced that the SYS 6040 (antibody-drug conjugate) developed by the group has been approved in China...

Zhitong FinanceMar 21 05:55 ET

Express News | CSPC Pharmaceutical - Sys6040 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in China From Nmpa

ReutersMar 21 05:53 ET

Special Contributor 大V: Deng Shengxing: The direction of Hong Kong stocks is unpredictable, it is advisable to focus on defensive stocks.

Hang Seng Index support level: 23600 resistance level: 24800. The Hang Seng Index closed at 24219 on Thursday (20th), down 551 points or 2.2%. The total market turnover for the day reached 294.8 billion yuan. The National Index fell 213 points or 2.3%, ending at 8950. The Technology Index dropped sharply by 204 points or 3.4%, closing at 5836. After Tencent's (00700) earnings announcement, multiple brokerages raised the Target Price, but the stock price fell 3.8% for the day, closing at 519.5 yuan, with turnover reaching 26.157 billion yuan. CSPC PHARMA (01093) rose 2.6% against the trend, being the best-performing blue chip. ALI HEALTH (002...

Jinwu Financial NewsMar 20 21:37 ET

Express News | CSPC Pharmaceutical - FY Revenue for CSPC Innovation Pharmaceutical RMB1.98 Bln

ReutersMar 20 09:34 ET

CSPC PHARMA: FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2024

HKEXMar 20 09:33 ET · Announcements

How strong are the Hong Kong pharmaceutical stocks right now? The Innovative Drugs Index has risen over 30% this year, reaching a near 16-month high.

① The Innovative Drugs Index in the Hong Kong stock market has increased by over 30% this year; why can it compete with Technology stocks? ② There has been a "small peak" in the commercialization of individual stocks; how do Institutions perceive the future market direction?

cls.cnMar 20 04:36 ET